Literature DB >> 16930686

Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.

George C Engelmayr1, Virna L Sales, John E Mayer, Michael S Sacks.   

Abstract

Bone marrow-derived mesenchymal stem cells (BMSCs) are relatively accessible and exhibit a pluripotency suitable for cardiovascular applications such as tissue-engineered heart valves (TEHVs). Recently, Sutherland et al. [From stem cells to viable autologous semilunar heart valve. Circulation 2005; 111(21): 2783-91] demonstrated that BMSC-seeded TEHV can successfully function as pulmonary valve substitutes in juvenile sheep for at least 8 months. Toward determining appropriate mechanical stimuli for use in BMSC-seeded TEHV cultivation, we investigated the independent and coupled effects of two mechanical stimuli physiologically relevant to heart valves-cyclic flexure and laminar flow (i.e. fluid shear stress)-on BMSC-mediated tissue formation. BMSC isolated from juvenile sheep were expanded and seeded onto rectangular strips of nonwoven 50:50 blend poly(glycolic acid) (PGA) and poly(l-lactic acid) (PLLA) scaffolds. Following 4 days static culture, BMSC-seeded scaffolds were loaded into a novel flex-stretch-flow (FSF) bioreactor and incubated under static (n=12), cyclic flexure (n=12), laminar flow (avg. wall shear stress=1.1505 dyne/cm(2); n=12) and combined flex-flow (n=12) conditions for 1 (n=6) and 3 (n=6) weeks. By 3 weeks, the flex-flow group exhibited dramatically accelerated tissue formation compared with all other groups, including a 75% higher collagen content of 844+/-278 microg/g wet weight (p<0.05), and an effective stiffness (E) value of 948+/-233 kPa. Importantly, collagen and E values were not significantly different from values measured for vascular smooth muscle cell (SMC) -seeded scaffolds incubated under conditions of flexure alone [Engelmayr et al. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 2005; 26(2): 175-87], suggesting that BMSC-seeded TEHV can be optimized to yield results comparable to SMC-seeded TEHV. We thus demonstrated that cyclic flexure and laminar flow can synergistically accelerate BMSC-mediated tissue formation, providing a basis for the rational design of in vitro conditioning regimens for BMSC-seeded TEHV.

Entities:  

Mesh:

Year:  2006        PMID: 16930686     DOI: 10.1016/j.biomaterials.2006.07.045

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  39 in total

1.  A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology.

Authors:  George C Engelmayr; Lorenzo Soletti; Sarah C Vigmostad; Stephanus G Budilarto; William J Federspiel; Krishnan B Chandran; David A Vorp; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2008-02-06       Impact factor: 3.934

2.  A novel cylindrical biaxial computer-controlled bioreactor and biomechanical testing device for vascular tissue engineering.

Authors:  Michael T Zaucha; Julia Raykin; William Wan; Robert Gauvin; Francois A Auger; Lucie Germain; Thomas E Michaels; Rudolph L Gleason
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 3.  Engineering stem cell niches in bioreactors.

Authors:  Meimei Liu; Ning Liu; Ru Zang; Yan Li; Shang-Tian Yang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 4.  Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding.

Authors:  Juhui Qiu; Yiming Zheng; Jianjun Hu; Donghua Liao; Hans Gregersen; Xiaoyan Deng; Yubo Fan; Guixue Wang
Journal:  J R Soc Interface       Date:  2013-10-23       Impact factor: 4.118

Review 5.  Directed stem cell differentiation by fluid mechanical forces.

Authors:  Luigi Adamo; Guillermo García-Cardeña
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

6.  A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.

Authors:  Sharan Ramaswamy; Steven M Boronyak; Trung Le; Andrew Holmes; Fotis Sotiropoulos; Michael S Sacks
Journal:  J Biomech Eng       Date:  2014-12       Impact factor: 2.097

7.  Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering.

Authors:  Nafiseh Masoumi; Aurélie Jean; Jeffrey T Zugates; Katherine L Johnson; George C Engelmayr
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

8.  A phenomenological model for mechanically mediated growth, remodeling, damage, and plasticity of gel-derived tissue engineered blood vessels.

Authors:  Julia Raykin; Alexander I Rachev; Rudolph L Gleason
Journal:  J Biomech Eng       Date:  2009-10       Impact factor: 2.097

9.  The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.

Authors:  Sharan Ramaswamy; Danielle Gottlieb; George C Engelmayr; Elena Aikawa; David E Schmidt; Diana M Gaitan-Leon; Virna L Sales; John E Mayer; Michael S Sacks
Journal:  Biomaterials       Date:  2009-11-26       Impact factor: 12.479

10.  Viscoelastic properties of the aortic valve interstitial cell.

Authors:  W David Merryman; Paul D Bieniek; Farshid Guilak; Michael S Sacks
Journal:  J Biomech Eng       Date:  2009-04       Impact factor: 2.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.